|
|
| Friday, 13 February, 2009 |
| Session 1 - Chairman: John Semple |
| 09.25 |
Introduction |
Drew Provan (London) |
| 09:30 |
Overview of the immunology of autoimmune disease |
John Semple (Toronto) |
| 10.15 |
Coffee break |
|
| 10:45 |
What role do B cells play in autoimmunity ? |
Donald Siegel (Philadelphia) |
| 11:30 |
Current understanding of T cells in autoimmunity |
Hans Wadenvik (Sweden) |
| 12:15 |
Lunch |
|
| Session 2 - Chairman: Drew Provan |
| 14:15 |
Epidemiology of autoimmune disease & role of registry studies |
Ameet Sarpatwari (London) |
| 15:00 |
Pathogenesis and management of autoimmune complications of lymphoid malignancies |
Steve Devereux (London) |
| 15:45 |
Coffee break |
|
| 16:15 |
What's new in TTP ? |
Marie Scully (London) |
| 17:00 |
Autoimmune neutropenia: investigation and clinical management |
Paul Moss (Birmingham) |
| 17:45 |
Finish |
|
| 18:00 |
Coktails |
|
| 20:00 |
Dinner |
|
|
|
|
| Saturday, 14 February, 2009 |
| Session 3 - Chairman: Roberto Stasi |
| 09:30 |
The evolution of clinical management of ITP |
Adrian Newland (London) |
| 10:15 |
Evolution of terminology used for ITP: a consensus statement |
Marco Ruggeri (Vicenza) |
| 11:00 |
Coffee break |
|
| 11:30 |
Advances in ITP therapy |
Drew Provan (London) |
| 12:15 |
Potential trigger factors in ITP and role of Helicobater pylori in pathogenesis of ITP |
Roberto Stasi (Rome) |
| 13:00 |
Lunch |
|
| Session 4 - Chairmen: Drew Provan (Londres), John Semple (Toronto), Roberto Stasi (Rome), Adrian Newland (London) |
| 14:00 - 14:30 |
Free communications |
|
| 14:45 |
Coffee break |
|
| 15:15 -15:45 |
Free Communications |
|
| 16:00 |
Poster viewing session |
|
| 17:00 |
Finish |
|
|
|
| Sunday, 15 February, 2009 |
| Session 5 - Chairman: Adrian Newland |
| 09:15 |
Current concepts in autoimmune haemolytic anaemia |
Stan Urbaniak (Aberdeen) |
| 10:00 |
Overview of Evan's syndrome in children and adults |
Marc Michel (Créteil) |
| 10:45 |
Coffee Break |
|
| 11:15 |
Pure red cell aplasia |
Nicole Casadevall (Paris) |
| 12:00 |
Where should we focus our research in autoimmune disease and what does the future hold for clinical management options ? |
John Semple (Toronto) & Adrian Newland (London) |
| 12:45 |
Conference closure |
|
|
ESH Gold Institutional Partner
ESH Gold Institutional Partner
